Venture Capitalists News Hubb
Advertisement Banner
  • Home
  • Venture Capital Market
  • Venture Capital Funding
  • Contact
No Result
View All Result
  • Home
  • Venture Capital Market
  • Venture Capital Funding
  • Contact
No Result
View All Result
Venture Capitalists News Hubb
No Result
View All Result
Home Venture Capital Funding

Deep science incubator C-CAMP sees 7 startups raise $70M in 4 months

admin by admin
August 25, 2022
in Venture Capital Funding


The Centre for Cellular and Molecular Platforms (C-CAMP) has announced that seven of its incubated deep science startups have raised over $70 million since the turn of the financial year (April-July 2022).

All seven have been associated with C-CAMP for over a decade, with some still on campus while others have set up shop as far away as Boston. While three companies raised Series B rounds, one received a strategic investment from a pharmaceutical giant.

String Bio raised $20 million led by Woodside Energy Group, among others. The company works on converting methane, a potent greenhouse gas, into products for animal nutrition, crop inputs, and biodegradable polymers.

Sea6 Energy raised $18.5 million led by BASF Venture Capital and other investors. The startup has built a proprietary large-scale method of cultivating seaweed, which can be used to build environmentally friendly products for agriculture, animal health, food, bioplastics, and renewable chemicals.

Bugworks has raised $18 million led by Lightrock and other investors. It is developing and testing a new broad-spectrum anti-bacterial drug. There has not been a new drug innovation in the space worldwide since the 1960s, according to C-CAMP director Dr Taslimarif Saiyad.

Achira has earned a strategic investment to the tune of Rs 25 crore for 21.05% of the company’s stake from pharma giant Cipla. It is building rapid, quantitative diagnostic tests.

Other C-CAMP companies which raised money in the last few months include cancer-immune therapeutics firm Zumutor ($6.2 million), stem cell development startup Eyestem ($6.4 million), and 3D tissue printing platform Pandorum ($4.8 million).

“These early-stage innovation bets have started coming to fruition, which is exciting for their science as well as India’s deep-tech innovation space,” said Dr Saiyed. “Together, these seven stars are addressing humanity’s most pressing problems in healthcare, agriculture, and environment.”



Source link

Tags: AchiraBugworksc-campEyestemJust InPandorum TechnologiesSea6 EnergyString BioZumutor Biologics
Previous Post

Subscriptions Can Curb Reliance on Trading Fees

Next Post

Web3 Startup Comm Raises $5M in Bid to Compete With Discord

Next Post

Web3 Startup Comm Raises $5M in Bid to Compete With Discord

Recommended

Web3 Watch: Yuga Labs Adds to Portfolio, Nike Creates NFT Marketplace

3 months ago

The Capital Quest | Apis backs Bengaluru fintech Money View at near-unicorn valuation

1 month ago

Impressions from Pocket Gamer Connects in London

2 weeks ago

Earth observation satellite in orbit, ISRO terms mission ‘unique’

2 months ago

Sensex ends over 293 points lower on last trading day of 2022; Nifty declines 86 points

1 month ago

GBTC Not Interested in Redemptions, but Considering Other Options

2 months ago

© 2022 Venture CapitaLists News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • Venture Capital Market
  • Venture Capital Funding
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • Venture Capital Market
  • Venture Capital Funding
  • Contact

© 2022 Venture Capitalists News Hubb All rights reserved.